Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(42.9%)

N/A

2(28.6%)

Phase 2

2(28.6%)

7Total

Phase 1(3)

N/A(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06103396Phase 1Unknown

Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)

Role: lead

NCT06103409Phase 1Unknown

MSCs for the Treatment of Burn Wounds

Role: lead

NCT05975892Phase 1Unknown

Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration

Role: lead

NCT05445089Phase 2Completed

Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients

Role: lead

NCT04545307Phase 2Completed

Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis

Role: collaborator

NCT01493297Not ApplicableCompleted

Effects of Vitamin A and Carotenoids on Iron Absorption

Role: collaborator

NCT01477112Not ApplicableCompleted

Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals

Role: lead

All 7 trials loaded